Journal Watch · Frontiers in Immunology · 2026

Reprogramming the wound microenvironment: identity remodeling strategies for fibroblasts, keratinocytes, and macrophages.

This work not only offers a novel intervention paradigm for the core challenges of treating chronic non-healing wounds like diabetic foot ulcers, but also delivers a panoramic theoretical framework and practical guidance for precision reprogramming therapy-from fundamental mechanisms to clinical translation.

Wang J, Chen M, Wei J et al.Frontiers in Immunology3 min readPharma relevance 40/100

DOI: 10.3389/fimmu.2026.1892931PMID: 42548532Study type: review / perspective

TL;DR

This work not only offers a novel intervention paradigm for the core challenges of treating chronic non-healing wounds like diabetic foot ulcers, but also delivers a panoramic theoretical framework and practical guidance for precision reprogramming therapy-from fundamental mechanisms to clinical translation.

Key findings

  • Remedying the principal weaknesses of existing reviews-overemphasis on technique listing, weak mechanistic integration, and lack of translational critique-we dissect the key molecular mechanisms layer by layer and critically evaluate the core clinical-translation bottlenecks, including safety, spatiotemporal precision, and model systems.
  • Finally, we spotlight emerging frontiers such as single-cell multi-omics navigation, AI-driven temporally programmed smart materials, and trained immunity, and discuss how they propel the field from proof-of-concept toward a precision systems-engineering paradigm of "personalized diagnosis → intelligent sequential delivery → closed-loop healing monitoring".
  • This work not only offers a novel intervention paradigm for the core challenges of treating chronic non-healing wounds like diabetic foot ulcers, but also delivers a panoramic theoretical framework and practical guidance for precision reprogramming therapy-from fundamental mechanisms to clinical translation.

What they did

Herein, we propose a systematic "four-dimensional technology toolbox" for wound cell reprogramming, comprising transcription factor-mediated, small-molecule-induced, epigenetic and metabolic regulation, and nanomaterial-assisted delivery. Using this toolbox as the main thread, we comprehensively integrate three core cell-identity reprogramming strategies: fibroblasts (from a profibrotic scar-forming phenotype to a pro-regenerative repair-competent phenotype), keratinocytes (restoring the endogenous regenerative capacity of keratinocytes to reconstruct the epidermal barrier), and macrophages (from a pro-inflammatory pathological state to a reparative homeostatic phenotype).

Full abstract (original)

Background: The core pathology of chronic non-healing wounds is the dysfunction of wound-repair cells-a molecular defect that conventional passive therapies can hardly correct at its root. Cell reprogramming techniques, by actively rewriting cell identity, have therefore brought a paradigm shift to wound repair.

What they did: Herein, we propose a systematic "four-dimensional technology toolbox" for wound cell reprogramming, comprising transcription factor-mediated, small-molecule-induced, epigenetic and metabolic regulation, and nanomaterial-assisted delivery. Using this toolbox as the main thread, we comprehensively integrate three core cell-identity reprogramming strategies: fibroblasts (from a profibrotic scar-forming phenotype to a pro-regenerative repair-competent phenotype), keratinocytes (restoring the endogenous regenerative capacity of keratinocytes to reconstruct the epidermal barrier), and macrophages (from a pro-inflammatory pathological state to a reparative homeostatic phenotype).

Results & conclusions: Remedying the principal weaknesses of existing reviews-overemphasis on technique listing, weak mechanistic integration, and lack of translational critique-we dissect the key molecular mechanisms layer by layer and critically evaluate the core clinical-translation bottlenecks, including safety, spatiotemporal precision, and model systems. Finally, we spotlight emerging frontiers such as single-cell multi-omics navigation, AI-driven temporally programmed smart materials, and trained immunity, and discuss how they propel the field from proof-of-concept toward a precision systems-engineering paradigm of "personalized diagnosis → intelligent sequential delivery → closed-loop healing monitoring". This work not only offers a novel intervention paradigm for the core challenges of treating chronic non-healing wounds like diabetic foot ulcers, but also delivers a panoramic theoretical framework and practical guidance for precision reprogramming therapy-from fundamental mechanisms to clinical translation.

Abstract © the authors / Frontiers in Immunology (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.3389/fimmu.2026.1892931 · PubMed 42548532.

Why it matters for pharma & biotech

  • Relevant to Immunology teams tracking Frontiers in Immunology for new targets, mechanisms and biomarkers.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • As a review, this paper synthesises prior studies rather than reporting new experimental data; weight it accordingly.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Frontiers in Immunology study find?

This work not only offers a novel intervention paradigm for the core challenges of treating chronic non-healing wounds like diabetic foot ulcers, but also delivers a panoramic theoretical framework and practical guidance for precision reprogramming therapy-from fundamental mechanisms to clinical translation.

What type of study is this?

It is a review / perspective, published in Frontiers in Immunology in 2026. Herein, we propose a systematic "four-dimensional technology toolbox" for wound cell reprogramming, comprising transcription factor-mediated, small-molecule-induced, epigenetic and metabolic regulation, and nanomaterial-assisted delivery.

Where can I read the original paper?

The original is at the publisher via DOI 10.3389/fimmu.2026.1892931. PubMed ID: 42548532. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Wang J, Chen M, Wei J et al.. Reprogramming the wound microenvironment: identity remodeling strategies for fibroblasts, keratinocytes, and macrophages.. Frontiers in Immunology (2026). DOI: 10.3389/fimmu.2026.1892931.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/reprogramming-the-wound-microenvironment-identity-remodeling-strategies-892931/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides